Royalty Pharma PLC Sustainability Reports
Royalty Pharma plc operates as a major buyer of biopharmaceutical royalties and a leading funder of innovation across the life sciences ecosystem. The company acquires income streams generated by major approved and development-stage therapies from academic institutions, research hospitals, and pharmaceutical innovators.
Sector: Finance & insurance
Country: United States
Exchange: Nasdaq
LEI: 549300FGFN7VOK8BZR03
FIGI: BBG00V1L5ZR1
11 reports from 2021 to 2025